Has hospitality been unfairly targeted?
11/24/20 • 12 min
It employs nearly one in ten UK workers, but it’s the industry set to suffer the most when England's new tier system comes into force. CEO of UKHospitality, Kate Nicholls tells Theodora Louloudis why limited evidence of infection in pubs and restaurants means the sector has been wrongly singled out, with ‘devastating’ consequences.
Read more on Christmas rules: https://bit.ly/361oNwP |
Read more on travel quarantine changes: https://bit.ly/371PVLG |
'Dosing error in trials led to Oxford vaccine's 90 per cent efficacy by accident': https://bit.ly/39bzCOU |
For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |
Email: [email protected] |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hosted on Acast. See acast.com/privacy for more information.
It employs nearly one in ten UK workers, but it’s the industry set to suffer the most when England's new tier system comes into force. CEO of UKHospitality, Kate Nicholls tells Theodora Louloudis why limited evidence of infection in pubs and restaurants means the sector has been wrongly singled out, with ‘devastating’ consequences.
Read more on Christmas rules: https://bit.ly/361oNwP |
Read more on travel quarantine changes: https://bit.ly/371PVLG |
'Dosing error in trials led to Oxford vaccine's 90 per cent efficacy by accident': https://bit.ly/39bzCOU |
For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |
Email: [email protected] |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hosted on Acast. See acast.com/privacy for more information.
Previous Episode
How promising is Remdesivir?
Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remdesivir. They discuss how useful it is, whether big pharma is solely driven by profit and the prognosis for severe coronavirus sufferers in the second wave.
Read more on the Oxford vaccine: https://bit.ly/2UVfPet |
Read more on Brexit talks: https://bit.ly/36V8f8Y |
Read more on the new quarantine-free list: https://bit.ly/3lMs88H |
For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |
Email: [email protected] |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Hosted on Acast. See acast.com/privacy for more information.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/coronavirus-the-latest-402846/has-hospitality-been-unfairly-targeted-56332469"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to has hospitality been unfairly targeted? on goodpods" style="width: 225px" /> </a>
Copy